(Q67949609)
Statements
Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group (English)
Rümke P
Kleeberg UR
MacKie RM
Lejeune FJ
Planting AS
Bröcker EB
Bierhorst JF
1 September 1992